Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence.
He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.
Researchers are discovering that “springing ahead” each March is connected with serious negative health effects.
With an mRNA or DNA vaccine, the goal is to make your body better able to recognize the very specific...
With up to 300 million scent receptors, dogs are among the best smell detectors in the animal world. The human...
Researchers have been steadily gathering important insights into the effects of COVID-19 on the body and brain. Two years into...
The CDC shortened the isolation from 10 days to five, followed by five days of wearing a mask for those...
With a flick of the wrist, the CDC unveiled its latest magic trick, effectively ending the pandemic in the hearts...
We see an increasing number of prescriptions for abortion medications - because of increasing access to abortion providers via telemedicine,...
Misinformation abounds in healthcare, as we saw during the pandemic. This is not a problem in healthcare, but a feature...
Most, but not all, experts agree that these changes are appropriate at this point in the pandemic. Many people, weary...
Portable air filters are an option for augmenting ventilation systems, but they typically cost hundreds of dollars, which puts them...
People typically think of food as calories, energy and sustenance. However, the latest evidence suggests that food also “talks” to...
Delta-8 THC is a hemp-derived compound that’s closely related to delta-9 THC – what’s commonly called THC and is the...
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy